Traditionally defensive stocks are expected to lag during bull markets, but that assumption is now obscuring an important shift. While defensives as a group have trailed global equities and significantly underperformed cyclical sectors, benefiting from accelerating growth, treating them as a single category misses what’s happening beneath the surface. A clear divergence is emerging: consumer staples continue to weaken, while healthcare has begun to turn higher.
With U.S. valuations stretched and the bull market increasingly mature, this split matters. The two largest
defensive sectors are no longer moving in tandem, challenging long-held portfolio assumptions and
carrying meaningful implications for risk management as market conditions evolve.
Why Staples are Losing Their Defensive Edge
Historically, food and beverage companies have been the textbook definition of safety. Today, they’re
facing a convergence of headwinds that weaken that role.
First, governments across the world are
leaning heavily on fiscal and monetary
stimulus to sustain growth and service
roughly $340 trillion in global debt. This
environment favors economically
sensitive sectors but squeezes staples.
Rising input costs, higher labor expenses,
and persistent margin pressure make it
harder for these companies to pass
inflation through to consumers already
stretched by higher living costs.
Second, consumption patterns are
changing. An aging population and a
cultural shift toward health, wellness, and
longevity is reshaping demand. That shift
is already visible in the data: booming
sales of GLP-1 weight-loss drugs are
coinciding with declining demand for
alcohol and sugary beverages. Staples
are fighting secular trends, not just
cyclical ones.
Healthcare’s Structural Tailwinds
A Defensive Rotation in Progress
Healthcare is also one of the earliest and most
impactful beneficiaries of artificial intelligence. AI
tools are accelerating drug discovery, improving
diagnostics, enabling more personalized patient
care, optimizing clinical trials, and driving
operational efficiency across the system, directly
enhancing productivity and profitability.
In other words, healthcare isn’t just defensive. It’s defensive with growth,
a rare and valuable combination in today’s market.
A Defensive Rotation in Progress
The takeaway is simple but important: the two sectors investors traditionally relied on for stability are no
longer moving in lockstep. Staples remain vulnerable to margin pressure and shifting consumer behavior,
while healthcare is supported by secular demand, innovation, and improving fundamentals.
If this divergence persists, and the underlying forces suggest it will, healthcare is likely to continue
separating itself from other defensive categories.
Bottom line: defensiveness alone is no longer enough. In a world shaped by debt, demographics, and
technological acceleration, the most resilient investments will be those that combine stability with
structural growth. Right now, healthcare stands apart.
At Flextion’s, we’ve identified several healthcare-focused funds and ETFs that score highly across our evaluation framework:
- Schwab Health Care Fund
- Horizon Kinetics Medical ETF
- Vanguard Health Care Fund
- BlackRock Health Sciences Opportunities Portfolio
- State Street Health Care Select SPDR ETF
- State Street Biotech SPDR ETF
- Fidelity MSCI Health Care ETF
- State Street Pharmaceuticals SPDR ETF
- iShares Genomics, Immunology & Health Care ETF
Download the article
Flextion is a breakthrough platform for evaluating fund strategy returns, helping investors identify managers at a pivotal turning point—those poised to outperform after a period of underperformance. Designed by seasoned portfolio managers, Flextion bridges the gap between “clock time” and “market time,” empowering investors to unlock long-term value and uncover hidden performance potential.